Evaluation of pneumonia on smokers
Închide
Articolul precedent
Articolul urmator
64 3
Ultima descărcare din IBN:
2024-01-09 12:33
SM ISO690:2012
COCIORVĂ-BUTNARI, Daniela, ŢERNĂ, Eudochia, TALMACI, Cornelia. Evaluation of pneumonia on smokers. In: Perspectives of the Balkan medicine in the post COVID-19 era: The 37th Balkan Medical Week. The 8th congress on urology, dialysis and kidney transplant from the Republic of Moldova “New Horizons in Urology”, Ed. 37, 7-9 iunie 2023, Chişinău. București: Balkan Medical Union, 2023, Ediția 37, p. 286. ISSN Print: ISSN 1584-9244 ISSN-L 1584-9244 Online: ISSN 2558-815X.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Perspectives of the Balkan medicine in the post COVID-19 era
Ediția 37, 2023
Congresul "Perspectives of the Balkan medicine in the post COVID-19 era"
37, Chişinău, Moldova, 7-9 iunie 2023

Evaluation of pneumonia on smokers


Pag. 286-286

Cociorvă-Butnari Daniela, Ţernă Eudochia, Talmaci Cornelia
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
 
Disponibil în IBN: 6 ianuarie 2024


Rezumat

Introduction. People who smoke are vulnerable to lung infections caused by a wide range of pathogens. The increased susceptibility to respiratory infections is explained both by the effect of cigarette smoke components on the airway epithelium, but also by the immunological changes in both cell-mediated and humoral immunity. Objective of the study. The presentation of clinical, imaging, bacteriological aspects on smoking patients with pneumonia. Material and methods. The clinical, paraclinical and imaging data of 74 patients hospitalized with communityacquired pneumonia, 53 of which are smokers and 21 - non-smokers. Results. The average age was 57 years (18-84 years). According to the CURB65 score, we found that community-acquired pneumonia with moderate and severe evolution prevailed on smokers, constituting 71.7% of cases, while on non-smokers prevailed pneumonia with mild evolution - 57.2% of cases. The radiological examination revealed the bilateral localization of the infiltrative process on 41.5% smoking patients, versus 33.3% on non-smokers. The cause of pneumonia on smokers was confirmed in 61.4% of cases, and on non-smokers in 52.4% of cases. The staphylococcal infection was present in 13.3% of smokers, versus 4.8% of non-smokers (P˂0.05). Conclusions. Pneumonia at smokers evolved with a higher degree of severity and bilateral localization. The broad etiological spectrum included bacteria that had a lower share on non-smokers.